Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference28 articles.
1. Estimated Cancer Incidence, Mortality and Prevelance Worlwide in 2012;International Agency for Research on Cancer,2012
2. Therapeutic drug monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry;Haouala;J. Chromatogr. B,2009
3. Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born;Schweizer;Ther. Adv. Urol.,2012
4. Population pharmacokinetic analysis of abiraterone in chemotherapy-naıve and docetaxel-treated patients with metastatic castration-resistant prostate cancer;Stuyckens;Clin. Pharmacokinet.,2014
5. Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer;Li;Nature,2015
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献